[1]
R. Hidayat, N. N. Soeroso, E. Syahruddin, D. Cahyadi, and Setiaputra, “Programmed Death Ligand 1 (PD-L1) Expression in Lung Adenocarcinoma Patients”, Respir Sci, vol. 1, no. 3, pp. 162-165, Jun. 2021.